SILLAJEN BIOTHERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Apr 2025)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86317022
- Registration number
- 5498035
- Mark type
- Stylized text
- Filed
- 23 Jun 2014
- Published for opposition
- 24 Feb 2015
- Registered
- 19 Jun 2018
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 042 — Scientific and technological services: Providing information in the field of research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
Owner
- SillaJen Biotherapeutics, Inc., San Francisco, CA, US
- SillaJen Biotherapeutics, Inc., San Francisco, CA, US
- SillaJen Biotherapeutics, Inc., San Francisco, CA, US
Prosecution history
- 04 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 19 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Mar 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Mar 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 17 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Apr 2018 — USE AMENDMENT FILED